492 Endometrial cancer: the role of prognostic factors and their impact on recurrence pattern. (4th December 2020)
- Record Type:
- Journal Article
- Title:
- 492 Endometrial cancer: the role of prognostic factors and their impact on recurrence pattern. (4th December 2020)
- Main Title:
- 492 Endometrial cancer: the role of prognostic factors and their impact on recurrence pattern
- Authors:
- Parpinel, Giulia
Fuso, Luca
Laudani, Maria Elena
Carapezzi, Annalisa
Badellino, Enrico
Petronio, Nicoletta
Ribotta, Marisa
Barboni, Martina
Ferrero, Annamaria
Zola, Paolo - Abstract:
- Abstract : Introduction/Background: The rate of recurrence of endometrial cancer is 11–19%. It is related to different prognostic factors which define specific risk classes in order to decide for an adjuvant treatment. The objective of this study is to evaluate how prognostic factors influence the probability and pattern of recurrence. Methodology: This multicentric observational retrospective study was conducted on 552 patients treated for endometrial cancer between February 2011–2019. The considered parameters were: age, BMI (Body Mass Index), surgery, stage, LVSI (Lymphovascular Space Involvement), myometrial infiltration, histological grade, lymph node involvement, adjuvant therapy, relapse. DFS (Disease Free Survival) and OS (Overall Survival) were stratified by the presence or absence of prognostic factors. Results: The rate of recurrence was 14, 7%. Median time to recurrence was 15 months and 5-years OS was 84%. We observed an increase from 6 to 30% in the distance metastasis rate associated with positive LVSI. Monovariate analysis showed a correlation between DFS and advanced stage (O.R. II 6.7; III-IV 9.2 p=0, 0001), positive lymph nodes (O.R. 3.7; p=0, 04), myometrial infiltration (O.R. 3.9 p=0, 0001) and LVSI (O.R. 3.5 p=0, 005). Similar results were observed considering OS and grading (p=0, 002). We conducted a Cox multivariate analysis on the ESGO/ESMO/ESTRO risk class classification and results were statistically significant for both DFS (p=0, 003) and OS (p=0,Abstract : Introduction/Background: The rate of recurrence of endometrial cancer is 11–19%. It is related to different prognostic factors which define specific risk classes in order to decide for an adjuvant treatment. The objective of this study is to evaluate how prognostic factors influence the probability and pattern of recurrence. Methodology: This multicentric observational retrospective study was conducted on 552 patients treated for endometrial cancer between February 2011–2019. The considered parameters were: age, BMI (Body Mass Index), surgery, stage, LVSI (Lymphovascular Space Involvement), myometrial infiltration, histological grade, lymph node involvement, adjuvant therapy, relapse. DFS (Disease Free Survival) and OS (Overall Survival) were stratified by the presence or absence of prognostic factors. Results: The rate of recurrence was 14, 7%. Median time to recurrence was 15 months and 5-years OS was 84%. We observed an increase from 6 to 30% in the distance metastasis rate associated with positive LVSI. Monovariate analysis showed a correlation between DFS and advanced stage (O.R. II 6.7; III-IV 9.2 p=0, 0001), positive lymph nodes (O.R. 3.7; p=0, 04), myometrial infiltration (O.R. 3.9 p=0, 0001) and LVSI (O.R. 3.5 p=0, 005). Similar results were observed considering OS and grading (p=0, 002). We conducted a Cox multivariate analysis on the ESGO/ESMO/ESTRO risk class classification and results were statistically significant for both DFS (p=0, 003) and OS (p=0, 0001). Conclusion: Almost all the considered prognostic factors influence the presence of recurrence, but the stage is the most important factor while LVSI correlates with distance metastasis. The definition of the risk factors must be considered to develop targeted therapeutic pathways. Disclosures: The authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 30(2020)Supplement 4
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 30(2020)Supplement 4
- Issue Display:
- Volume 30, Issue 4, Part 4 (2020)
- Year:
- 2020
- Volume:
- 30
- Issue:
- 4
- Part:
- 4
- Issue Sort Value:
- 2020-0030-0004-0004
- Page Start:
- A43
- Page End:
- A43
- Publication Date:
- 2020-12-04
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2020-ESGO.77 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19776.xml